Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
#3361 FOLFOX-bevacizumab chemotherapy in patients with progressive metastatic neuroendocrine tumors
Introduction: Well-differentiated neuroendocrine tumors (NETs) are relatively rare, highly vascularized neoplasms. Antiangiogenic drugs have shown efficacy in patients with advanced NETs. Bevacizumab is a well-known antiangiogenic monoclonal antibody.
Conference:
Presenting Author:
Authors: Lacombe C, Perrier M, Hentic O, Brixi H, Rebours V,
Keywords: neuroendocrine tumor, antiangiogenic therapy, VEGF, well-differentiated,
Introduction: Although 24-hour urinary 5-hydroxyindolacetic acid (24u5HIAA) is a key biomarker in midgut NET, it may be inaccurate and inconvenient.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author: de Mestier L
Authors: de Mestier L, Savagner F, Brixi H, Do Cao C, Dominguez S,
Keywords: neuroendocrine tumor, carcinoid syndrome, 5-hydroxyindolacetic acid, biomarker, diagnosis,
#914 French Cohort of Familial Midgut Carcinoid Tumors
Introduction: Familial Midgut Carcinoid Tumors (FMCT) are a rare and poorly described entity defined by the occurrence of a midgut carcinoid tumor in at least two first-degree relatives.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: de Mestier L
Authors: De Mestier L, Fleury C, Pasmant E, Brixi H, Murat A,
Keywords: carcinoid tumor, family, heredity ,
#900 Renal Effects of Streptozocin: Preliminary Results of the STREPTOTOX Study
Introduction: Based on old studies, Streptozocin (STZ) is known to have some renal toxicity.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Mitry E
Authors: Mitry E, Brixi H, Lecomte T, Lombard-Bohas C, Seitz J,
Keywords: digestive neuroendocrine tumors, streptozotocin, nephrotoxicity, chemotherapy,
#824 Metachronous Functioning Syndromes in Sporadic Pancreatic Neuroendocrine Tumors (PNET)
Introduction: A metachronous functioning syndrome (MFS) may develop during the evolution of PNET initially functioning or not.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: de Mestier L
Authors: De Mestier L, Hentic O, Cros J, Brixi H, Walter T,
Keywords: neuroendocrine tumors, pancreas, functioning syndrome, natural evolution,